Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Linking clinical trial data with real-world data for enhanced clinical evidence generation: methodological considerations and recommendations

Randomized controlled trials (RCTs) remain the cornerstone of causal inference on the safety and efficacy of medicinal products. But their limited follow-up, controlled settings, and narrowly defined data collection to balance the burden to patients and maintain study feasibility often results in unaddressed important...

A. Meinecke, J. Diaz-Decaro, Kathleen M. Gavin et al. · 1 citation
Open access Sep 2026

International Society for Pharmacoepidemiology in Action: Advancing Public Health Through Evidence‐Based Advocacy

Key Points Public health faces increasingly complex challenges for pharmacoepidemiology: monitoring and evaluating the safety and effectiveness of medicines in real‐world populations, predicting and responding to emerging diseases and outbreaks, overcoming inequities in drug access and outcomes, managing risks from wid...

G. Sarri, J. Diaz-Decaro, M. Burcu et al. · 0 citations
Review Open access Aug 2026

Use of real-world evidence in the U.S. Food and Drug Administration and the European Medicines Agency approvals of oncology products supported by single-arm trials (2022-2025)

RWE is increasingly used to support oncology SATs and holds promise as supportive or contextual evidence in regulatory decision-making and methodological limitations commonly included small sample sizes, population heterogeneity, missing or unmeasured covariates, non-aligned outcome assessments, post-hoc design, and no...

Le Su, Lei Chen, R. Mamtani et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.